Scientists are still investigating potential causes and treatments for autoimmune conditions. Here’s what to know. View on ...

A Pierce County woman alleges Rainier Recovery's negligent care contributed to her son's death, exposing a pattern of ...

When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...

Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.

Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...

When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year. That was pricey, but her insurance covered most of it, and the drug slowed the disease’s ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the trillions of bacteria, fungi, and viruses that colonize our digestive tract—and ...

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care. As the costs of multiple sclerosis (MS) treatments continue to rise, it is ...